Home>
US Stocks>
Takeda Pharmaceutical Company

Takeda Pharmaceutical Company share price today

(TAK)

Takeda Pharmaceutical Company share price is $13.17 & ₹1,120.70 as on 24 Dec 2024, 2.30 'hrs' IST

$13.17

▲

0.07

(0.53%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Takeda Pharmaceutical Company share price in Dollar and Rupees. Guide to invest in Takeda Pharmaceutical Company from India. Also see the sentimental analysis on Indian investors investing in Takeda Pharmaceutical Company. Get details on the Indian mutual funds that are investing in Takeda Pharmaceutical Company. Get Analyst recommendations and forecasts along with all the Takeda Pharmaceutical Company's financials.

Takeda Pharmaceutical Company share price movements

Today's Low: $13.04
Today's High: $13.18
$13.17
0.99%
Downside
Day's Volatility :1.02%
Upside
0.04%
52 Weeks Low: $12.58
52 Weeks High: $15.08
$13.17
4.52%
Downside
52 Weeks Volatility :16.61%
Upside
12.67%

Takeda Pharmaceutical Company Returns

Period	Takeda Pharmaceutical Company Limited	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.49%	-10.6%	0.0%
6 Months	0.92%	-6.0%	0.0%
1 Year	-6.83%	2.2%	0.0%
3 Years	-4.52%	-0.9%	-21.1%

Takeda Pharmaceutical Company Key Statistics

in dollars & INR

Previous Close	$13.1
Open	$13.12
Today's High	$13.175
Today's Low	$13.04
Market Capitalization	$42.0B
Today's Volume	$1.8M
52 Week High	$15.08
52 Week Low	$12.575
Revenue TTM	$4.5T
EBITDA	$1.3T
Earnings Per Share (EPS)	$0.59
PE Ratio	22.05
Dividend Yield	5.01%
Profit Margin	6.38%
Quarterly Earnings Growth YOY	0.05%
Return On Equity TTM	4.15%

How to invest in Takeda Pharmaceutical Company from India?

It is very easy for Indian residents to invest directly in Takeda Pharmaceutical Company from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Takeda Pharmaceutical Company stock in both Indian Rupees (INR) and US Dollars (USD). Search for Takeda Pharmaceutical Company or TAK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Takeda Pharmaceutical Company or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Takeda Pharmaceutical Company shares which would translate to 0.065 fractional shares of Takeda Pharmaceutical Company as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Takeda Pharmaceutical Company, in just a few clicks!

Returns in Takeda Pharmaceutical Company for Indian investors in Rupees

Investment Value

₹1,00,000

Takeda Pharmaceutical Company investment value today

Current value as on today

₹95,992

Returns

₹4,008

(-4.01%)

Returns from Takeda Pharmaceutical Company Stock

₹6,330 (-6.33%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Takeda Pharmaceutical Company

39%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Takeda Pharmaceutical Company on INDmoney from India has grown in the last 30 days as on Dec 24, 2024. 39% more investors are searching Takeda Pharmaceutical Company in the last 30 days versus the previous period.

Global Institutional Holdings in Takeda Pharmaceutical Company

Capital Research Global Investors
0.41%
Morgan Stanley - Brokerage Accounts
0.17%
Mondrian Investment Partners Ltd
0.16%
Arrowstreet Capital Limited Partnership
0.15%
Goldman Sachs Group Inc
0.14%
Millennium Management LLC
0.11%

Analyst Recommendation on Takeda Pharmaceutical Company

Buy

52%Buy

47%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Takeda Pharmaceutical Company(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Takeda Pharmaceutical Company

What analysts predicted

Upside of 18.84%

Current:

$13.17

Target:

$15.65

Insights on Takeda Pharmaceutical Company

Price Movement
In the last 7 days, TAK stock has moved down by -1.4%
Decreasing Revenue
Takeda Pharmaceutical Company Limited has experienced a decline in revenue for the last two quarters. Revenue fell from $1207.99 billion to $1176.03 billion, reflecting an average decrease of 2.7% per quarter.
Decreasing Net Profit
Takeda Pharmaceutical Company Limited has experienced a decline in its net profit over the last four quarters. The profit has decreased from 105.72 billion to 92.04 billion dollars, which represents an average decrease of 4.4% each quarter.
TAK vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 18.9% return, outperforming this stock by 25.7%
Price to Sales
Takeda Pharmaceutical Company Limited has a Price-to-Sales Ratio of $0.0, meaning that investors are not currently willing to pay anything for each dollar of sales the company makes. In comparison, investors are willing to pay $4.0 for every $1 of sales for Haleon Plc, indicating much higher investor confidence in Haleon's sales performance.

Takeda Pharmaceutical Company Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$18.9B	↑ 18.45%
Net Income	$981.7M	↓ 41.61%
Net Profit Margin	5.2%	↓ 5.36%

	FY20	Y/Y Change
Revenue	$30.6B	↑ 56.93%
Net Income	$411.6M	↓ 59.46%
Net Profit Margin	1.34%	↓ 3.86%

	FY21	Y/Y Change
Revenue	$29.4B	↓ 2.84%
Net Income	$3.5B	↑ 749.9%
Net Profit Margin	11.76%	↑ 10.42%

	FY22	Y/Y Change
Revenue	$30.2B	↑ 11.61%
Net Income	$1.9B	↓ 38.81%
Net Profit Margin	6.45%	↓ 5.31%

	FY23	Y/Y Change
Revenue	$30.1B	↑ 12.85%
Net Income	$2.4B	↑ 37.8%
Net Profit Margin	7.87%	↑ 1.42%

	FY24	Y/Y Change
Revenue	$28.5B	↑ 5.87%
Net Income	$961.7M	↓ 54.56%
Net Profit Margin	3.38%	↓ 4.49%

	Q2 FY23	Q/Q Change
Revenue	$7.4B	↑ 9.09%
Net Income	$-339.7M	↓ 254.27%
Net Profit Margin	-4.6%	↓ 7.86%

	Q3 FY23	Q/Q Change
Revenue	$7.1B	↑ 0.0%
Net Income	$-324.9M	↑ 0.0%
Net Profit Margin	-4.6%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$7.7B	↑ 6.53%
Net Income	$735.0M	↓ 320.11%
Net Profit Margin	9.51%	↑ 14.11%

	Q1 FY24	Q/Q Change
Revenue	$8.1B	↑ 8.71%
Net Income	$635.8M	↓ 9.91%
Net Profit Margin	7.88%	↓ 1.63%

	Q2 FY24	Q/Q Change
Revenue	$7.6B	↑ 0.0%
Net Income	$602.7M	↑ 0.0%
Net Profit Margin	7.88%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$1.2T	↓ 2.65%
Net Income	$92.0B	↓ 3.36%
Net Profit Margin	7.83%	↓ 0.05%

	FY19	Y/Y Change
Profit	$12.9B	↑ 12.78%

	FY20	Y/Y Change
Profit	$20.5B	↑ 53.14%

	FY21	Y/Y Change
Profit	$20.3B	↑ 0.09%

	FY22	Y/Y Change
Profit	$20.8B	↑ 11.74%

	FY23	Y/Y Change
Profit	$20.8B	↑ 13.05%

	FY24	Y/Y Change
Profit	$18.9B	↑ 1.76%

	Q2 FY23	Q/Q Change
Profit	$4.9B	↑ 8.22%

	Q3 FY23	Q/Q Change
Profit	$4.7B	↑ 0.0%

	Q4 FY23	Q/Q Change
Profit	$5.1B	↑ 4.6%

	Q1 FY24	Q/Q Change
Profit	$4.4B	↓ 10.05%

	Q2 FY24	Q/Q Change
Profit	$4.2B	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$781.7B	↑ 18.77%

	FY19	Y/Y Change
Operating Cash Flow	$3.0B	↓ 13.07%
Investing Cash Flow	$-25.5B	↑ 2937.97%
Financing Cash Flow	$26.5B	↓ 1003.13%

	FY20	Y/Y Change
Operating Cash Flow	$6.2B	↑ 103.89%
Investing Cash Flow	$2.7B	↓ 110.3%
Financing Cash Flow	$-9.4B	↓ 134.12%

	FY21	Y/Y Change
Operating Cash Flow	$9.3B	↑ 50.94%
Investing Cash Flow	$3.6B	↑ 34.72%
Financing Cash Flow	$-10.0B	↑ 8.27%

	FY22	Y/Y Change
Operating Cash Flow	$9.5B	↑ 11.1%
Investing Cash Flow	$-1.7B	↓ 150.35%
Financing Cash Flow	$-9.0B	↓ 1.66%

	FY23	Y/Y Change
Operating Cash Flow	$7.3B	↓ 13.0%
Investing Cash Flow	$-4.5B	↑ 206.42%
Financing Cash Flow	$-5.3B	↓ 33.74%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$1.4B	↓ 32.27%
Investing Cash Flow	$-1.9B	↓ 56.1%
Financing Cash Flow	$-994.8M	↑ 2031.14%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.3B	↑ 0.0%
Investing Cash Flow	$-2.2B	↑ 22.73%
Financing Cash Flow	$-951.5M	↑ 0.0%

Takeda Pharmaceutical Company Technicals Summary

Sell

Neutral

Buy

Takeda Pharmaceutical Company is currently in a neutral trading position according to technical analysis indicators.

Takeda Pharmaceutical Company Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Takeda Pharmaceutical Company Limited	-2.89%	0.92%	-6.83%	-4.52%	-33.8%
Neurocrine Biosciences Inc.	6.54%	0.25%	3.22%	60.28%	25.45%
Haleon Plc Spon Ads	1.15%	13.07%	18.17%	30.77%	30.77%
Zoetis Inc.	-7.76%	-1.87%	-15.68%	-33.13%	23.91%
Viatris Inc.	-6.29%	21.44%	16.9%	-8.41%	-23.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Takeda Pharmaceutical Company Limited	22.05	22.05	1.63	0.33	0.04	0.03	0.05	4365.91
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.53	28.53	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.68	30.68	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Takeda Pharmaceutical Company Limited	Buy	$42.0B	-33.8%	22.05	6.38%
Neurocrine Biosciences Inc.	Buy	$13.7B	25.45%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.1B	30.77%	28.53	10.75%
Zoetis Inc.	Buy	$73.8B	23.91%	30.68	26.55%
Viatris Inc.	Hold	$14.5B	-23.38%	224.4	-5.87%

Takeda Pharmaceutical Company Dividend announcements

Takeda Pharmaceutical Company Dividends March, 2022
In the quarter ending March,2022. Takeda Pharmaceutical Company has declared dividend of $0.33
Read More

About Takeda Pharmaceutical Company

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.

Organization	Takeda Pharmaceutical Company
Employees	49281
CEO	Mr. Christophe Weber
Industry	Health Technology

Management People of Takeda Pharmaceutical Company

Name	Title
Mr. Christophe Weber	President, CEO & Representative Director
Dr. Seigo Izumo	Chair of Management Board
Mr. Milano Furuta	CFO & Director
Mr. Haruhiko Hirate	Member of Management Board
Mr. Salvatore Alesci M.D., Ph.D.	Member of Management Board and Head of R&D Global Science & Biomedical Policy
Norimasa Takeda	Chief Accounting Officer & Corporate Controller
Mr. Iwaaki Taniguchi	Senior Vice President of Corporate Finance & Controlling Department
Mr. Gabriele Ricci	Chief Data & Technology Officer
Mr. Christopher David O'Reilly	Global Head of Investor Relations & Global Finance
Mr. Yoshihiro Nakagawa	Global General Counsel

Important FAQs about investing in Takeda Pharmaceutical Company from India :

What is Takeda Pharmaceutical Company share price today?

Takeda Pharmaceutical Company share price today stands at $13.17, Open: $13.12 ; Previous Close: $13.10 ; High: $13.18 ; Low: $13.04 ; 52 Week High: $15.08 ; 52 Week Low: $12.58. The stock opens at $13.12, after a previous close of $13.10. The stock reached a daily high of $13.18 and a low of $13.04, with a 52-week high of $15.08 and a 52-week low of $12.58.

Can Indians buy Takeda Pharmaceutical Company shares?

Yes, Indians can invest in the Takeda Pharmaceutical Company (TAK) from India.

With INDmoney, you can buy Takeda Pharmaceutical Company at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Takeda Pharmaceutical Company at zero transaction cost.

How can I buy Takeda Pharmaceutical Company shares from India?

It is very easy to buy Takeda Pharmaceutical Company from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Takeda Pharmaceutical Company be purchased?

Yes, you can buy fractional shares of Takeda Pharmaceutical Company with INDmoney app.

What are the documents required to start investing in Takeda Pharmaceutical Company stocks?

To start investing in Takeda Pharmaceutical Company, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.